Showing results (1611-1620 of 2,323) with videos related to
Sort By:
Pageof 233
Expert Opinion on Therapeutic Targets|September 24, 2020
Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer: learning from the past to design future strategiesSilvia Pegoraro, Gloria Ros, Michela Sgubin, et al.Expert Opinion on Therapeutic Targets|September 23, 2020
Targeting TANK-binding kinase 1 (TBK1) in cancerOr-Yam Revach, Shuming Liu, Russell W JenkinsExpert Opinion on Therapeutic Targets|January 27, 2021
Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapyCorentin Louis, Julien Edeline, Cédric CoulouarnExpert Opinion on Therapeutic Targets|November 12, 2021
Novel immune targets for the treatment of triple-negative breast cancerChiara Corti, Eleonora Nicolò, Giuseppe CuriglianoExpert Opinion on Therapeutic Targets|November 25, 2021
The mechanisms and therapeutic targets of ferroptosis in cancerLong Ye, Fengyan Jin, Shaji K Kumar, et al.Expert Opinion on Therapeutic Targets|November 15, 2021
Retinal vein occlusion: drug targets and therapeutic implicationsAlessandro Arrigo, Francesco BandelloExpert Opinion on Therapeutic Targets|December 7, 2021
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profilesMichele Simbolo, Samantha Bersani, Caterina Vicentini, et al.Expert Opinion on Therapeutic Targets|November 22, 2021
Uncovering key targets of success for immunotherapy in pancreatic cancerAndrea Pretta, Eleonora Lai, Mara Persano, et al.Expert Opinion on Therapeutic Targets|October 27, 2022
The adenosine A2A receptor is a therapeutic target in neurological, heart and oncogenic diseasesRafael Franco, Alejandro Lillo, Gemma Navarro, et al.Expert Opinion on Therapeutic Targets|October 11, 2022
Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related moleculesJiali Tang, Fang Liu, Mark E Cooper, et al.Pageof 233